Cargando…
Inhibition of host Ogr1 enhances effector CD8(+) T-cell function by modulating acidic microenvironment
Immunotherapies for cancer, such as immune checkpoint blockade or adoptive T-cell transfer, can lead to a long-lasting clinical response. But the therapeutic response rate remains low on account of many tumors that have evolved sophisticated strategies to evade immune surveillance. Solid tumors are...
Autores principales: | Cao, Lin, Li, Weisha, Yang, Xingjiu, Zhang, Wenlong, Li, Mengyuan, Zhang, Haizeng, Qin, Chuan, Chen, Xiaohong, Gao, Ran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571096/ https://www.ncbi.nlm.nih.gov/pubmed/34158625 http://dx.doi.org/10.1038/s41417-021-00354-0 |
Ejemplares similares
-
Correction: Inhibition of host Ogr1 enhances effector CD8(+) T-cell function by modulating acidic microenvironment
por: Cao, Lin, et al.
Publicado: (2021) -
Clinical data analysis reveals the role of OGR1 (GPR68) in head and neck squamous cancer
por: Zhang, Wenlong, et al.
Publicado: (2020) -
Summary of animal models of myelodysplastic syndrome
por: Li, Weisha, et al.
Publicado: (2021) -
Novel spontaneous myelodysplastic syndrome mouse model
por: Li, Weisha, et al.
Publicado: (2021) -
Involvement of the Wnt/β-Catenin signaling pathway in the heterogenous nuclear ribonucleoprotein K-driven inhibition of proliferation and migration in head and neck squamous cell carcinoma
por: Liu, Hongfei, et al.
Publicado: (2020)